You might also like
Tear-off pad on AML with FLT3 mutation
This tear-off pad has been created to provide clear explanations about FLT3-mutated AML for patients.
Find out more
ADMIRAL trial (2019)
Publication
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
Find out moreFLT3 testing methods
Video
Dr Lambert explains the different testing methods of FLT3, the differences between them, logistical aspects and the reimbursement process in Belgium.
Intended for: practitioners
Why: up-to-date knowledge
When: watch now
Language: French, Dutch subtitles
Duration: 4 minutes
MAT-BE-NON-2023-00133 - November 2023